RecruitingNCT06806488
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
Retrospective Observational Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
160 participants
Start Date
May 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This is a purely retrospective and observational monocentric study
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This is a retrospective study reviewing the medical records of patients previously diagnosed and treated for marginal zone lymphoma — a slow-growing type of blood cancer — at a single hospital between 2012 and 2018, to better understand how the disease progresses and responds to treatment.
**You may be eligible if...**
- You were diagnosed with marginal zone lymphoma
- You were treated at this hospital between December 2012 and December 2018
- You are 18 or older
**You may NOT be eligible if...**
- There are no specific exclusion criteria listed for this study
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06806488